The direct effects of stored blood products may worsen prognosis of cancer patients; shall we transfuse or not? An explanation of the adverse oncological consequences of blood product transfusion with a testable hypothesis driven experimental research protocol-Reference-Cited by-同舟云学术

The direct effects of stored blood products may worsen prognosis of cancer patients; shall we transfuse or not? An explanation of the adverse oncological consequences of blood product transfusion with a testable hypothesis driven experimental research protocol

Published:2008-10 Issue:4 Volume:71 Page:489-492
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Upile Tahwinder,Jerjes Waseem,Sandison Ann,Singh Sandeep,Rhys-Evans Peter,Sudhoff Holger,Hopper Colin

Publisher

Elsevier BV

Subject

General Medicine

Reference15 articles.

1. Blood transfusion and tumour growth: evidence from laboratory animals;Francis;Lancet,1981

2. Perioperative blood transfusions: indications and options;McFarland;Chest,1999

3. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates;Edvardsen;Am J Hematol,2001

4. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets;Werther;Scand J Clin Lab Invest,2002

5. The red cell storage lesion and its implication for transfusion;Chin-Yee;Transfus Sci,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between blood transfusion and outcomes of free flap head and neck cancer surgery;American Journal of Otolaryngology;2024-11

2. Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma;PLOS ONE;2018-10-22

3. Current relevance of hypoxia in head and neck cancer;Oncotarget;2016-05-21

4. The Impact of Perioperative Packed Red Blood Cell Transfusion on Survival in Epithelial Ovarian Cancer;International Journal of Gynecologic Cancer;2013-11

5. The use of specific anti-growth factor antibodies to abrogate the oncological consequences of transfusion in head & neck squamous cell carcinoma: an in vitro study;Head & Neck Oncology;2012-05-16